Lassa Virus Vaccines: A Critical Tool for Saving Lives, Strengthening Economies, and Enhancing Global Pandemic Preparedness

Title

Lassa Virus Vaccines: A Critical Tool for Saving Lives, Strengthening Economies, and Enhancing Global Pandemic Preparedness

Authors

1. Basilia Ezeigwe, University of Lagos, Lagos, Student, Nigeria

Abstract

The infectious hemorrhagic disease known as Lassa fever, which is native to West Africa, continues to pose a serious risk to public health and has far-reaching societal and economic consequences. There is no human-use vaccination for this virus, even though it keeps popping up. The creation of vaccinations against the Lassa virus is discussed in this article as a crucial measure to reduce casualties, lessen financial losses, and strengthen international readiness for a pandemic. This study highlights the need to invest globally in Lassa virus vaccine research and distribution by looking at vaccine candidates being developed, their possible economic advantages, and their role in improving healthcare systems. Looking forward to future global health policies, the research emphasises the significance of vaccinations within the framework of pandemic preparation, learning from the experiences of COVID-19.

Keywords

Lassa virus Lassa fever Vaccine development Non-invasive diagnosis Public health Economic stability Pandemic preparedness Viral hemorrhagic fever Ensemble classifier Emerging infectious diseases

PDF

This browser does not support PDFs. Please download the PDF to view it: View the PDF.

Conclusion

Lassa virus vaccines represent a vital opportunity to save lives, protect economies, and strengthen global health systems in preparation for future pandemics. The development of a safe and effective Lassa vaccine would reduce the disease's health and economic burdens in endemic regions while offering valuable lessons for pandemic preparedness. By investing in vaccine research, production, and distribution, the global community can ensure a more resilient future in the face of emerging infectious diseases.

Reference

1. -

Author Contribution

All study-related tasks, from conception and design to data analysis and manuscript creation, were solely managed by the author.

Funding

No grants from public, commercial, or non-profit funding agencies supported the research, authorship, or publication of this article.

Software Information

No specific software or tools were used in the research.

Conflict of Interest

All authors declare the absence of any conflicts of interest.

Acknowledge

My gratitude goes to those who assisted in this study and manuscript preparation, and to the anonymous reviewers for their constructive insights.

Data availability

There are no data available for sharing in this work.